BIOMAT Database Logo BIOMAT Database Logo

The Search for Plasmodium falciparum histidine-rich protein 2/3 Deletions in Zambia and Implications for Plasmodium falciparum histidine-rich protein 2-Based Rapid Diagnostic Tests. 2019

Tamaki Kobayashi, and Jay Sikalima, and Jonathan B Parr, and Mike Chaponda, and Jennifer C Stevenson, and Philip E Thuma, and Modest Mulenga, and Steven R Meshnick, and William J Moss, and For The Southern And Central Africa International Centers Of Excellence For Malaria Research
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

We attempted to identify Plasmodium falciparum histidine-rich protein 2/3 (pfhrp2/3) deletions among rapid diagnostic test (RDT)-negative but PCR- or microscopy-positive P. falciparum-infected individuals in areas of low transmission (Choma District, 2009-2011) and high transmission (Nchelenge District, 2015-2017) in Zambia. Through community-based surveys, 5,167 participants were screened at 1,147 households by P. falciparum histidine-rich protein 2 (PfHRP2)-based RDTs. Slides were made and dried blood spots were obtained for molecular analysis. Of 28 samples with detectable P. falciparum DNA, none from Nchelenge District were pfhrp2/3 negative. All eight samples from Choma District had detectable pfhrp3 genes, but pfhrp2 was undetectable in three. DNA concentrations of pfhrp2-negative samples were low (< 0.001 ng/μL). These findings suggest that PfHRP2-based RDTs remain effective tools for malaria diagnosis in Nchelenge District, but further study is warranted to understand the potential for pfhrp2/3 deletions in southern Zambia where malaria transmission declined over the past decade.

UI MeSH Term Description Entries
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000953 Antigens, Protozoan Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered. Protozoan Antigens
D015024 Zambia A republic in southern Africa, south of DEMOCRATIC REPUBLIC OF THE CONGO and TANZANIA, and north of ZIMBABWE. Its capital is Lusaka. It was formerly called Northern Rhodesia. Northern Rhodesia,Rhodesia, Northern,Republic of Zambia
D015800 Protozoan Proteins Proteins found in any species of protozoan. Proteins, Protozoan
D016054 DNA, Protozoan Deoxyribonucleic acid that makes up the genetic material of protozoa. Protozoan DNA
D016778 Malaria, Falciparum Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations. Plasmodium falciparum Malaria,Malaria, Plasmodium falciparum
D017353 Gene Deletion A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus. Deletion, Gene,Deletions, Gene,Gene Deletions
D059788 Dried Blood Spot Testing Techniques for using whole blood samples collected on filter paper for a variety of clinical laboratory tests. Dried Blood Spot Analysis,Dried Blood Spot Method

Related Publications

Tamaki Kobayashi, and Jay Sikalima, and Jonathan B Parr, and Mike Chaponda, and Jennifer C Stevenson, and Philip E Thuma, and Modest Mulenga, and Steven R Meshnick, and William J Moss, and For The Southern And Central Africa International Centers Of Excellence For Malaria Research
Plasmodium falciparum histidine rich protein-2 diversity and the implications for PfHRP 2: based malaria rapid diagnostic tests in Ghana.
February 2016, Malaria journal,
Tamaki Kobayashi, and Jay Sikalima, and Jonathan B Parr, and Mike Chaponda, and Jennifer C Stevenson, and Philip E Thuma, and Modest Mulenga, and Steven R Meshnick, and William J Moss, and For The Southern And Central Africa International Centers Of Excellence For Malaria Research
Evaluating Malaria Rapid Diagnostic Tests and Microscopy for Detecting Plasmodium Infection and Status of Plasmodium falciparum Histidine-Rich Protein 2/3 Gene Deletions in Southeastern Nigeria.
May 2024, The American journal of tropical medicine and hygiene,
Tamaki Kobayashi, and Jay Sikalima, and Jonathan B Parr, and Mike Chaponda, and Jennifer C Stevenson, and Philip E Thuma, and Modest Mulenga, and Steven R Meshnick, and William J Moss, and For The Southern And Central Africa International Centers Of Excellence For Malaria Research
Plasmodium falciparum Histidine-Rich Protein 2 and 3 Gene Deletions and Their Implications in Malaria Control.
May 2020, Diseases (Basel, Switzerland),
Tamaki Kobayashi, and Jay Sikalima, and Jonathan B Parr, and Mike Chaponda, and Jennifer C Stevenson, and Philip E Thuma, and Modest Mulenga, and Steven R Meshnick, and William J Moss, and For The Southern And Central Africa International Centers Of Excellence For Malaria Research
Variation in Plasmodium falciparum Histidine-Rich Protein 2 (Pfhrp2) and Plasmodium falciparum Histidine-Rich Protein 3 (Pfhrp3) Gene Deletions in Guyana and Suriname.
January 2015, PloS one,
Tamaki Kobayashi, and Jay Sikalima, and Jonathan B Parr, and Mike Chaponda, and Jennifer C Stevenson, and Philip E Thuma, and Modest Mulenga, and Steven R Meshnick, and William J Moss, and For The Southern And Central Africa International Centers Of Excellence For Malaria Research
Spatiotemporal dynamics of Plasmodium falciparum histidine-rich protein 2 and 3 deletions in Peru.
November 2022, Scientific reports,
Tamaki Kobayashi, and Jay Sikalima, and Jonathan B Parr, and Mike Chaponda, and Jennifer C Stevenson, and Philip E Thuma, and Modest Mulenga, and Steven R Meshnick, and William J Moss, and For The Southern And Central Africa International Centers Of Excellence For Malaria Research
Identification of optimal epitopes for Plasmodium falciparum rapid diagnostic tests that target histidine-rich proteins 2 and 3.
April 2012, Journal of clinical microbiology,
Tamaki Kobayashi, and Jay Sikalima, and Jonathan B Parr, and Mike Chaponda, and Jennifer C Stevenson, and Philip E Thuma, and Modest Mulenga, and Steven R Meshnick, and William J Moss, and For The Southern And Central Africa International Centers Of Excellence For Malaria Research
Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests.
May 2010, Malaria journal,
Tamaki Kobayashi, and Jay Sikalima, and Jonathan B Parr, and Mike Chaponda, and Jennifer C Stevenson, and Philip E Thuma, and Modest Mulenga, and Steven R Meshnick, and William J Moss, and For The Southern And Central Africa International Centers Of Excellence For Malaria Research
Implications of Parasites Lacking Plasmodium falciparum Histidine-Rich Protein 2 on Malaria Morbidity and Control When Rapid Diagnostic Tests Are Used for Diagnosis.
April 2017, The Journal of infectious diseases,
Tamaki Kobayashi, and Jay Sikalima, and Jonathan B Parr, and Mike Chaponda, and Jennifer C Stevenson, and Philip E Thuma, and Modest Mulenga, and Steven R Meshnick, and William J Moss, and For The Southern And Central Africa International Centers Of Excellence For Malaria Research
Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria.
August 2006, Journal of clinical microbiology,
Tamaki Kobayashi, and Jay Sikalima, and Jonathan B Parr, and Mike Chaponda, and Jennifer C Stevenson, and Philip E Thuma, and Modest Mulenga, and Steven R Meshnick, and William J Moss, and For The Southern And Central Africa International Centers Of Excellence For Malaria Research
Transcription and expression of Plasmodium falciparum histidine-rich proteins in different stages and strains: implications for rapid diagnostic tests.
January 2011, PloS one,
Copied contents to your clipboard!